Skip to content
AnalystLens

James Hardie Industries Annual Report, Year Ended Mar 31, 2023

Filing Date
Filed May 16, 2023
Period End
March 31, 2023
Securities
JHXJHIUF
One revenue dollarkept$0.14
In the record · 2016–202610-K1210-Q18-K401

JHX filed 12 annual reports (10-K), 1 quarterly reports (10-Q) and 401 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Oct ’26Oct ’26

Summary

Summary of the 20-F filed May 16, 2023. Cited figures are marked; the original filing is the authoritative source.

James Hardie Industries plc, filing its Annual Report on Form 20-F for the fiscal year ended 31 March 2023, reported record net sales of US$3,777.1 milliona, up 4% from US$3,614.7 million, driven by Price/Mix growth of 9% partly offset by a 5% volume decrease.

Operating income rose 9% to US$741.4 millionb, helped by a lower asbestos adjustments loss (US$37.0 million versus US$131.7 million), while net income increased 12% to US$512.0 million and diluted EPS was US$1.15 versus US$1.03. Management described a challenging macro environment, with high input costs and significant inflationary pressures weighing on segment results, and the filing notes Europe and Asia Pacific earnings declined. Liquidity and capital allocation shifted during the year.

Capital expenditures rose to US$591.3 millionc from US$257.8 million, including a US$378.4 million global capacity expansion spend, and operating cash flow fell to US$607.6 million from US$757.2 million. Gross debt increased to US$1,066.1 million from US$886.4 million, and the company repurchased 3.8 million shares for US$78.4 million under a program launched in November 2022. Cash and cash equivalents ended at US$113.0 million.

Looking ahead, management expects US residential end markets to contract significantly in fiscal 2024 versus fiscal 2023 and estimates fiscal 2024 capital expenditures of approximately US$550 milliond. The filing also discloses a US$977.1 million asbestos liability tied to the AICF funding agreement, a New Zealand weathertightness litigation matter, and a newly filed Australian securities class action.

Key Highlights

  1. Record net sales of US$3,777.1 million (up 4%), with Price/Mix growth of 9% partly offset by a 5% volume decline.
  2. Operating income rose 9% to US$741.4 million; net income rose 12% to US$512.0 million, with diluted EPS of US$1.15 versus US$1.03.
  3. North America Fiber Cement net sales increased 9% to US$2,787.6 million, with operating income margin of 27.5%, down 1.6 percentage points.
  4. Europe Building Products operating income fell 58% to US$26.5 million, with operating margin down 7.1 percentage points to 5.8%.
  5. Capital expenditures more than doubled to US$591.3 million, and the company expects approximately US$550 million in fiscal 2024 capex.
  6. Gross debt rose to US$1,066.1 million from US$886.4 million, and US$121.6 million remained available under the share buyback program.
  7. Management expects US residential end markets to contract significantly in fiscal 2024; the asbestos liability stood at US$977.1 million at 31 March 2023.

Follow one dollar

Of each $1.00 of revenue in FY2023, James Hardie Industries kept $0.14.

  1. Revenue$3.78B100.0%
  2. Cost of revenue−$2.47B65.3%
  3. Gross profit$1.31B34.7%
  4. Operating costs−$570.6M15.1%
  5. Operating income$741.4M19.6%
  6. Interest, other & tax−$229.4M6.1%
  7. Net income$512.0M13.6%
Computed from 10-KFY2023filed May 16, 2023Computed from this filing’s revenue, gross profit, operating income and net income · right columngrey figure: share of revenue

Where FY2023 revenue went

$3.78B
  • Cost of revenue: $2.47B, 65% of revenue
  • Net income: $512.0M, 14% of revenue
  • SG&A: $494.0M, 13% of revenue
  • R&D: $39.6M, 1.0% of revenue
  • Other operating costs: $37.0M, 1.0% of revenue
  • Interest, other & tax: $229.4M, 6.1% of revenue

Kept 14% as net incomeR&D $39.6M · 1.0%Other operating costs $37.0M · 1.0%

Full revenue history →

Financial Statements

FY2023 against FY2022

Line itemFY2023FY2022Change
Revenue$3.78B$3.61B+4.5%
Cost of Revenue$2.47B$2.30B+7.1%
Gross Profit$1.31B$1.31B−0.1%
R&D Expenses$39.60M$38.00M+4.2%
SG&A Expenses$494.00M$461.20M+7.1%
Operating Income$741.40M$682.60M+8.6%
Net Income$512.00M$459.10M+11.5%
EPS (Basic)$1.15$1.03+11.7%
EPS (Diluted)$1.15$1.03+11.7%
Shares Outstanding (Basic)445.10M444.90M0.0%
Shares Outstanding (Diluted)445.60M445.90M−0.1%

Frequently Asked Questions

  1. How did James Hardie perform financially in fiscal year 2023?

    Net sales rose 4% to US$3,777.1 million and net income rose 12% to US$512.0 million. Operating income increased 9% to US$741.4 million, aided by a smaller asbestos adjustments loss, while gross margin declined 1.6 percentage points to 34.7%.

  2. What is the outlook for the company's main US market?

    The filing states that management expects US residential end markets to contract significantly in fiscal year 2024 versus fiscal year 2023, with demand influenced by factors such as interest rates, mortgage affordability and home prices.

  3. Why did cash flow from operations decline and debt increase?

    Net cash provided by operating activities fell to US$607.6 million from US$757.2 million, largely due to a US$101.9 million working capital increase. Capital expenditures of US$591.3 million and dividend and buyback payments were funded partly through a US$190.0 million net increase in revolving credit borrowings, lifting gross debt to US$1,066.1 million.

  4. What asbestos-related obligations does the company face?

    The company funds the Asbestos Injuries Compensation Fund under the Amended and Restated Final Funding Agreement. The asbestos liability was US$977.1 million at 31 March 2023, and the company contributed US$109.6 million to the fund during the year, with approximately A$128 million expected in fiscal 2024.

  5. What litigation risks are disclosed?

    The filing discloses ongoing New Zealand weathertightness claims, with the Cridge appeal decision expected in calendar 2023 and the Waitakere matter settled in April 2023. It also describes an Australian class action filed on 8 May 2023 alleging misleading forward-looking statements, which the company is defending and for which no reserve has been recorded.